Durataf 25 mg Tablet is an antiviral medicine used to treat chronic hepatitis B (HBV) in adults and adolescents (aged 12 years and older, weighing at least 35 kg). Chronic hepatitis B is a long-term infection caused by the hepatitis B virus. Durataf 25 Tablet works by stopping the virus from multiplying in human cells, which helps to clear the infection.
Common side effects include headache, stomach pain, heartburn, tiredness, cough, upset stomach, back pain, joint pain and diarrhoea. These effects are usually mild, but tell your doctor if they persist or get worse. Rarely, some people may experience skin reactions or liver damage, so your doctor will monitor you closely during the early stages of treatment.
Before starting Durataf 25 mg Tablet, tell your doctor about your medical history, including any existing medical conditions such as HIV, liver or kidney disease, and any other health problems. Also tell your doctor about all the medicines you are taking, including prescription medicines such as oxcarbazepine, phenobarbital, phenytoin, rifabutin, rifampin, rifapentine, non-prescription medicines, herbal supplements and vitamins. Avoid smoking and alcohol as they may interfere with this medicine.
Take this Durataf 25 Tablet by mouth with a glass of water. Keep taking your Durataf 25 mg Tablet for as long as your doctor advises. The treatment duration depends on your condition and response to the medicine. Follow your doctor's directions closely, as incorrect use or overdose can lead to serious side effects. It might take several weeks or months to see improvement, so don't stop taking it unless your doctor says it's okay.
Chronic Hepatitis B is a long-term infection caused by the hepatitis B virus (HBV), leading to serious liver issues such as cirrhosis, liver cancer, and liver failure. This liver infection spreads through contact with blood, semen, vaginal fluids, or other bodily fluids. Durataf 25 mg Tablet is used to treat this condition.
Durataf 25 mg Tablet helps to reduce the amount of Hepatitis-B Virus in the body, which can help slow the progression of liver damage caused by the virus.
Durataf 25 Tablet can help whoever is suffering from liver disease. it can improve liver function in people with chronic Hepatitis-B Virus infection.
Durataf 25 mg Tablet may decrease the risk of complications including liver scarring (cirrhosis), liver cancer, and liver failure.
Durataf 25 mg Tablet may reduce the symptoms such as fatigue, abdominal pain, and loss of appetite and improve the quality of life.
All medications can cause side effects, but many people experience none or only minor ones. If you have any concerns or persistent side effects, let your doctor know.
You can take Durataf 25 mg Tablet with food. Follow your doctor's instructions on how long to use it, which will depend on your specific condition and how you respond to the treatment. It's important to take the medication exactly as prescribed to avoid serious side effects. It might take weeks or months to notice any benefits, so keep taking it until your doctor advises otherwise.
Durataf 25 mg Tablet is an antiviral drug that stops viruses from multiplying in human cells. This action prevents the virus from spreading and helps clear the infection.
It's usually best to avoid drinking alcohol while taking Durataf 25 mg Tablet as it can increase the risk of liver damage. If you do drink, try to limit your alcohol intake.
Durataf 25 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating which may affect your ability to drive a vehicle safely.It is important to follow your doctor's instructions and take essential precautions along with not driving a vehicle or operating heavy machinery if you are suffering from the side effects of this Durataf 25 Tablet.
Breastfeeding while taking Durataf 25 mg Tablet is not recommended because it can pass into breast milk and may harm the baby. If you are using Durataf 25 Tablet and breastfeeding, discuss the risks and benefits with your doctor. They can help you decide the best course of action for you and your baby's health.
The use of Durataf 25 mg Tablet during pregnancy can be considered if needed. There is limited information on the use of Durataf 25 Tablet in pregnant women. However, extensive data shows no risk of birth defects or toxicity to the fetus or newborn with tenofovir disoproxil. Animal studies also show no harmful effects on reproduction.
Durataf 25 mg Tablet is safe for patients with kidney disease. No dose changes are needed for adults or adolescents (12 years and older, weighing at least 35 kg) with a creatinine clearance (CrCl) of 15 mL/min or higher.
Durataf 25 mg Tablet is safe for use in liver disease patients. No dose adjustment is necessary for this type of patient.
1. Vemlidy, (tenofovir Alafenamide) Tablets, For Oral Use, Gilead Sciences, Product Leaflet
2. Vemlidy 25 Mg Film-coated Tablets, Gilead Sciences Ireland Uc, Product Monograph
3. Tenofovir Alafenamide, Drugs.com, Avaliable Form
4. Tenofovir Af (rx), Medscape.com, Avaliable Form